Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Incyte Corporation (INCY) vs Paychex, Inc. (PAYX) Price & Performance

Incyte CorporationTrade
Paychex, Inc.Trade

Price performance (Past 24H)

Key statistics

Incyte Corporation vs Paychex, Inc. — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Paychex, Inc. trades at $115.19 (market cap $40.98B). The key difference: Paychex, Inc. is the larger of the two by market cap, and Paychex, Inc. pays a 4.13% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.

INCYPAYX
Market Cap
$23.11B$40.98B
Sector
HealthIndustrials
52-Week High
$118.52$147.99
52-Week Low
$67.38$85.57
Enterprise Value
$19.13B$44.47B
Dividend Yield
4.13%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Read more on INCY

About Paychex, Inc.

Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.

Read more on PAYX